129 related articles for article (PubMed ID: 38522940)
1. Factors associated with low bone mineral density in Turner syndrome: a multicenter prospective observational study.
Ikegawa K; Koga E; Itonaga T; Sakakibara H; Kawai M; Hasegawa Y
Endocr J; 2024 Jun; 71(6):561-569. PubMed ID: 38522940
[TBL] [Abstract][Full Text] [Related]
2. Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome.
Holroyd CR; Davies JH; Taylor P; Jameson K; Rivett C; Cooper C; Dennison EM
Osteoporos Int; 2010 Dec; 21(12):2093-9. PubMed ID: 20135092
[TBL] [Abstract][Full Text] [Related]
3. Delay in estrogen commencement is associated with lower bone mineral density in Turner syndrome.
Nguyen HH; Wong P; Strauss BJ; Jones G; Ebeling PR; Milat F; Vincent A
Climacteric; 2017 Oct; 20(5):436-441. PubMed ID: 28523940
[TBL] [Abstract][Full Text] [Related]
4. Turner syndrome adolescents receiving growth hormone are not osteopenic.
Neely EK; Marcus R; Rosenfeld RG; Bachrach LK
J Clin Endocrinol Metab; 1993 Apr; 76(4):861-6. PubMed ID: 8473397
[TBL] [Abstract][Full Text] [Related]
5. A retrospective multicenter study of bone mineral density in adolescents and adults with Turner syndrome in Japan.
Itonaga T; Koga E; Nishigaki S; Kawai M; Sakakibara H; Hasegawa Y
Endocr J; 2020 Oct; 67(10):1023-1028. PubMed ID: 32554947
[TBL] [Abstract][Full Text] [Related]
6. The Effect of the Rate of Increase of Estrogen Replacement Therapy on Bone Mineral Density Accrual in Young Patients with Turner Syndrome.
Brander EPA; Keenahan LA; Sangi-Haghpeykar H; Graham M; Dietrich JE
J Pediatr Adolesc Gynecol; 2023 Aug; 36(4):353-357. PubMed ID: 36934800
[TBL] [Abstract][Full Text] [Related]
7. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
[TBL] [Abstract][Full Text] [Related]
8. Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome.
Chiarito M; Piacente L; Chaoul N; Pontrelli P; D'Amato G; Grandone A; Russo G; Street ME; Wasniewska MG; Brunetti G; Faienza MF
J Endocrinol Invest; 2022 Jun; 45(6):1255-1263. PubMed ID: 35237949
[TBL] [Abstract][Full Text] [Related]
9. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
10. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome.
Cleemann L; Hjerrild BE; Lauridsen AL; Heickendorff L; Christiansen JS; Mosekilde L; Gravholt CH
Eur J Endocrinol; 2009 Aug; 161(2):251-7. PubMed ID: 19447901
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal bone mineral content and density in Rett syndrome and their contributing factors.
Jefferson A; Fyfe S; Downs J; Woodhead H; Jacoby P; Leonard H
Bone; 2015 May; 74():191-8. PubMed ID: 25659951
[TBL] [Abstract][Full Text] [Related]
12. Artificially low cortical bone mineral density in Turner syndrome is due to the partial volume effect.
Soucek O; Schönau E; Lebl J; Sumnik Z
Osteoporos Int; 2015 Mar; 26(3):1213-8. PubMed ID: 25288443
[TBL] [Abstract][Full Text] [Related]
13. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey.
Gravholt CH; Vestergaard P; Hermann AP; Mosekilde L; Brixen K; Christiansen JS
Clin Endocrinol (Oxf); 2003 Jul; 59(1):89-96. PubMed ID: 12807509
[TBL] [Abstract][Full Text] [Related]
14. Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.
Costa AM; Lemos-Marini SH; Baptista MT; Morcillo AM; Maciel-Guerra AT; Guerra G
J Bone Miner Metab; 2002; 20(5):294-7. PubMed ID: 12203035
[TBL] [Abstract][Full Text] [Related]
15. Normal tempo of bone formation in Turner syndrome despite signs of accelerated bone resorption.
Cleemann L; Holm K; Kobbernagel H; Skouby SO; Kristensen B; Smedegaard H; Andersson AM; Cohen A; Gravholt CH
Horm Res Paediatr; 2011; 76(3):193-201. PubMed ID: 21791892
[TBL] [Abstract][Full Text] [Related]
16. Starting age of oestrogen-progestin therapy is negatively associated with bone mineral density in young adults with Turner syndrome independent of age and body mass index.
Nishigaki S; Itonaga T; Hasegawa Y; Kawai M
Clin Endocrinol (Oxf); 2021 Jul; 95(1):84-91. PubMed ID: 33872421
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution.
van den Bergh JP; Hermus AR; Spruyt AI; Sweep CG; Corstens FH; Smals AG
Osteoporos Int; 2001; 12(1):55-62. PubMed ID: 11305084
[TBL] [Abstract][Full Text] [Related]
18. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy.
Landin-Wilhelmsen K; Bryman I; Windh M; Wilhelmsen L
Clin Endocrinol (Oxf); 1999 Oct; 51(4):497-502. PubMed ID: 10583318
[TBL] [Abstract][Full Text] [Related]
20. Bone density in post-pubertal adolescent survivors of childhood brain tumors.
Cohen LE; Gordon JH; Popovsky EY; Sainath NN; Feldman HA; Kieran MW; Gordon CM
Pediatr Blood Cancer; 2012 Jun; 58(6):959-63. PubMed ID: 22431246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
